Efficacy Study of Sunitinib and Everolimus (Rotational Versus Sequential Arm) in Patients With Metastatic Clear Cell Renal Cancer (SUNRISES)
Read time: 1 mins
Last updated:11th Dec 2012
The objective of this study is to assess the progression-free survival, of patients who receive rotations of sunitinib and everolimus versus patients who receive sunitinib as a first line treatment followed by everolimus when progression occurs.
|Study start date||2012-12-11|